Patient Group Directions (PGDs) provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a doctor (or dentist) or non-medical prescriber.

PGDs are NOT intended as a substitute for individual prescribing where there is an opportunity in the care pathway for a medicine or medicines to be prescribed i.e. where an episode of care is planned.

PGDs must only include medicines with a UK marketing authorisation, in line with national legislation. Off-label use of a licensed medicine in a PGD is considered only when clearly justified by best clinical practice.

Only formulary drugs can be approved for inclusion on a PGD.

A PGD must only be written after careful consideration of all the available methods of administration and supply of medicines, including prescribing by medical or non-medical prescribers.


Policy Details

Download: N/A
Compiled by: Olatokunbo Ogunbanjo, Chief Pharmacist
Ratified by: Drug and Therapeutics Committee
Date Ratified: October 2021
Date Issued: October 2021
Review Date: October 2024
Target Audience: Doctors, Nurses, Pharmacy, Allied Health Care Professionals
Contact name: Olatokunbo Ogunbanjo, Chief Pharmacist


See also: